Trial intelligence / Profile preview

Maintenance Bee-Venom Immunotherapy at 6-Month Intervals

NCT00684476Phase 4Completed

Sponsor
Meir Medical Center
Start
Jun 2004
Modality
Peptides, Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of apis mellifera venom in bee venom allergy, sponsored by Meir Medical Center. Started Jun 2004; status: completed.

02

Drugs

apis mellifera venom
03

Conditions

bee venom allergy

Beyond the preview

Go deeper on NCT00684476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00684476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call